期刊文献+

异丙托溴铵联合沙丁胺醇和喘定治疗小儿哮喘的疗效及药理作用探讨 被引量:20

Curative Effect and Pharmacological Action of Ipratropium Bromide Combined with Salbutamol and Dyphylline in Treatment of Children with Asthma
原文传递
导出
摘要 本研究以小儿哮喘患儿为研究对象,观察异丙托溴铵联合沙丁胺醇和喘定治疗小儿哮喘的疗效,并探讨其药理作用。研究发现,观察组的总有效率(95.35%)高于对照组(76.74%)(p〈0.05)。观察组的FVC%、FEVI%、MMF%和MVV%均高于对照组(p〈0.05)。观察组的血清TNF—α、IL-6和IL-10水平均低于对照组(P〈0.05)。观察组CD4^+、CD8^及CD4^+/CD8^+比值低于对照组(p〈0.05)。异丙托溴铵联合沙丁胺醇和喘定治疗小儿哮喘具有较好的临床疗效,可提高患儿肺功能,减轻炎症反应,提高免疫功能。 In this research, we selected children with asthma as the research objects to observe the curative effect of ipratropium bromide combined with salbutamol and dyphylline in treatment for asthma children and explore the pharmacological actions. The results showed that the total effective rate (95.35%) of the observation group was higher than that of control group (76.74%) (p〈0.05). The FVC%, FEV1%, MMF% and MVV% in observation group were higher than those of control group (p〈0.05). The serum TNF-α, IL-6 and IL-10 levels in the observation group were all lower than those in control group (p 〈0.05). The CD4^+, CD8^+ and CD4^+/CD8^+ ratios of the observation group were lower than those of control group (p〈0.05). The ipratropium bromide combined with salbutamol and dyphylline in the treatment for asthma children had better clinical curative effect, which could improve the lung function of asthma children as well as the immune function, and reduce inflammatory response.
作者 吴果 Wu Guo(Department of Paediatrics, The Second People's Hospital of Changzhou City of Jiangsu Province, Changzhou, 21300)
出处 《基因组学与应用生物学》 CAS CSCD 北大核心 2018年第3期1066-1070,共5页 Genomics and Applied Biology
基金 国家自然科学基金(81660761)资助
关键词 小儿哮喘 异丙托溴铵 沙丁胺醇 喘定 Asthma in children, Ipratropium bromide, Salbutamol, Dyphylline
  • 相关文献

同被引文献219

引证文献20

二级引证文献145

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部